Samsung Bioepis biosimilar to Roche Herceptin wins FDA nod Farhat Nasim23 Jan 2019 9:00 AM ISTHerceptin, which generated sales of 7.01 billion Swiss francs in 2017, is one of the world’s most successful antibody drugs and has been a mainstay of...
Sun Pharma takes steps to ease governance concerns Farhat Nasim22 Jan 2019 5:19 PM ISTSun Pharma said on Tuesday it replaced Aditya Medisales with its wholly owned unit as the new distributor for its domestic formulations business. It...
Extradition process against 4 Sterling Biotech promoters initiated: ED tells court Medical Dialogues Bureau22 Jan 2019 1:17 PM ISTThe ED told the court that the four accused are reported to be in Italy and Nigeria and their extradition is required for probing the case.NEW DELHI:...
Zydus gets tentative USFDA nod to generic Esomeprazole Magnesium delayed release capsules Farhat Nasim22 Jan 2019 9:15 AM ISTEsomeprazole Magnesium reduces the amount of acid secreted by the stomach. The drug is used for the treatment of symptoms of gastroesophageal reflux...
Glaxo Smith Kline Chairman Philip Hampton to step down Farhat Nasim22 Jan 2019 9:00 AM IST"Following the announcement of our deal with Pfizer and the intended separation of the new consumer business, I believe this is the right moment to...
Wockhardt gets USFDA nod for generic Imatinib Mesylate tablets Farhat Nasim21 Jan 2019 12:58 PM ISTWockhardt's Imatinib Mesylate tablets are a generic version of Gleevec, marketed in the USA and other countries by Novartis.Mumbai: Drug firm...
Series of Recall: Lupin, Sun pharma, Glenmark recall products in US Farhat Nasim21 Jan 2019 11:09 AM ISTThe ongoing voluntary nationwide recall has been classified as Class-I and Class-II recall.New Delhi: Indian drug majors Lupin, Sun Pharma and...
Shilpa Medicare gets USFDA approval for Imatinib Mesylate Tablets Farhat Nasim21 Jan 2019 9:30 AM ISTImatinib Mesylate is a generic equivalent of the reference-listed drug (RLD) Gleevec (100mg and 400mg), which is used in the treatment of leukaemia as...
Lilly Lartruvo fails key trial, will no longer be prescribed Farhat Nasim21 Jan 2019 9:15 AM ISTLartruvo will continue to be available to patients who appear to be benefiting from it as global regulators determine the next steps for the...
Sun pharma seeks SEBI intervention after allegations of unfair trade practices Medical Dialogues Bureau20 Jan 2019 10:15 AM ISTAgainst the backdrop of reports that a second whistleblower complaint has been filed against it and shares taking a beating on the exchanges, Sun...
Teva Pharma receives US FDA approval for generic Sabril Garima20 Jan 2019 9:30 AM ISTTeva’s generic Sabril(vigabatrin) tablets are part of a single shared-system Risk Evaluation and Mitigation Strategy (REMS) program.U.S: The U.S. Food...
Sandoz launches SYMJEPI epinephrine syringe in the US Medical Dialogues Bureau20 Jan 2019 9:15 AM ISTSYMJEPI will be rolled out through a phased launch, first in the institutional setting – an established channel where Sandoz Inc. has significant...
